Cofoe Medical Makes Two Strategic Investments in Brain-Computer Interface Field

Source: Securities Times

People's Finance News, October 31stCofoe(301087) stated on October 30 after accepting institutional research that the company has participated in two strategic investments in the brain-computer interface field. One was the investment in Neulink Medical in 2024. The company focuses on implantable brain-computer interface technology, mainly developing bionic eye and bionic ear products. The other is the recent investment in Lizhi Intelligence. The company is committed to brain-computer intelligence andRobotThe development of embodied intelligence technology is expected to achieve strategic synergy with the company's rehabilitation assistive devices in the future, expanding intelligent rehabilitation solutions. Through forward-looking investments in cutting-edge fields such as brain-computer interfaces, Cofoe Medical Technology Co., Ltd. is actively exploring the integration of intelligent healthcare and neurotechnology, paving the way for new technological advantages and growth opportunities in areas like hearing rehabilitation, smart assistive devices, and precision health management.